论文部分内容阅读
急性脑血管病并应激性溃疡出血可使患者病情加重,病死率增高.我们应用洛赛克治疗急性脑血管病并应激性溃疡出血25例,并与西咪替丁治疗25例进行比较,效果显著,现报道如下.1 临床资料1.1 病例选择 选择住院治疗的急性脑血管病并应激性溃疡出血患者50例(均符合急性脑血管病并应激性溃疡出血的诊断标准).随机分为2组:洛赛克治疗组(以下称治疗组)25例,男18例,女7例,年龄为34～68岁,平均58.2岁,脑出血19例,脑梗塞5例,脑栓塞1例.西咪替丁治疗组(以下称对照组25例),男19例,女6例,年龄为39～67岁,平均59.4岁,脑出血20例,脑梗塞5例.
Acute cerebrovascular disease and stress ulcer bleeding may aggravate the patient’s condition and increase the mortality rate.We applied Losec to treat 25 cases of acute cerebrovascular disease and stress ulcer hemorrhage and compared with 25 cases of cimetidine , The effect is significant, are reported as follows.1 Clinical data1.1 case selection of hospitalized patients with acute cerebrovascular disease and stress ulcer bleeding in 50 patients (both in acute cerebrovascular disease and stress ulcer bleeding diagnostic criteria) random Divided into 2 groups: Losec treatment group (hereinafter referred to as treatment group) 25 cases, 18 males and 7 females, aged 34 to 68 years, mean 58.2 years, 19 cases of cerebral hemorrhage, cerebral infarction in 5 cases, cerebral embolism 1 case.Cimetidine treatment group (hereinafter referred to as the control group of 25 cases), 19 males and 6 females, aged 39 to 67 years, mean 59.4 years, 20 cases of cerebral hemorrhage, 5 cases of cerebral infarction.